1 / 1

Formulation Development Sterile Injectable | Pharmaceutical Formulation Development NCE

http://latitudepharma.com/ - Latitude Pharma is a forefront Formulation Development Contract Research Organization offering proprietary drug delivery system and high-efficiency formulations to the leading biotech and pharma companies. The company specializes in developing formulation for compounds that are highly insoluble, highly unstable and have low bioavailability. Latitude Pharma has a glorious record of over 800 successful formulation development projects for human and animal healthcare.

Download Presentation

Formulation Development Sterile Injectable | Pharmaceutical Formulation Development NCE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Formulation Development Service How Proprietary Techniques and Technology Has Become A Boon to Formulation Development Industry?   The growing demand for improving the bioavailability of generic and NCE drugs has caused the Formulation Development Industry to flourish. Bioavailability of drugs is directly promotional to the activity of a drug. Some of the most common factors that influence BA or Bioavailability of drugs include pH, solubility, size, metabolism rate, food interactions, drug interactions, drug taken with other drugs, psychological factors, polymorphism, drug formulation and drug delivery system. There are many Formulation and Deformulation Generic Drug Product Development companies that have fulfilled the need for drug bioavailability and introduced proprietary drug delivery systems on a large scale. One of such leading-edge companies is Latitude Pharma. The key responsibility of a Formulation Development Contract Research Organization is to conquer the complex formulation challenges for problematic drug candidates. For the drugs that are highly insoluble, highly unstable or having a poor bioavailability, special techniques are needed to enhance their efficacy or innovative drug delivery systems are required for easy administration and better results. Most of the leading and well-resourced formulation development companies tend to develop innovative solutions to eliminate the nuisances caused during drug administration like vein irritation, huge doses, lack of IP protection, poor absorption etc. Their goal is to combine advanced techniques and technology to develop better drug delivery systems and improved Human and Veterinary Animal Drug Formulation Development.       How Advanced Drug Delivery Systems Ease Up Drug Administration?   Every Formulation Development Service tends to develop formulations in which the API sufficiently bioavailable for the best results. The action of the drugs administrated in a human or animal body also depends on the mode of administration and drug delivery system. For the successful development of a drug, the companies like Latitude Pharma offers a wide range of delivery systems and formulation platforms like Nanoemulsion, PG Depot, ARTSS, RFAP, RTTF, 24H ER Tablets, Minispheres, Gel Patches or transdermal sprays and FEEDLETs. These delivery systems help in overcoming the common issues during bulky dosage, multiday drug delivery, 24 hours extended drug release, solubility of drugs, developing stable solutions and more. In this domain, not just the Parenteral IV Intravenous Drug Formulation Development is a big achievement fir easy drug administration but there are more successful projects including TOX Formulation, GLP Formulation, Formulation Development Sterile Injectable solutions and to name a few. The development in the novel carriers for drug administration is a great relief for pharma and biotech industry. For inquiries regarding capabilities, formulation services, and licensing opportunities, contact: Matthew A. Singer, PhD VP, Head of Business Development Tel:  858-546-0924, ext. 103 Email: matthewsinger@latitudepharma.com For more info visit http://latitudepharma.com/

More Related